NCT02011126: Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors |
|
|
| Withdrawn | 2 | 0 | NA | Imetelstat Sodium, GRN163L, GRN163L, Sodium Salt, Laboratory Biomarker Analysis | Children's Oncology Group, National Cancer Institute (NCI) | Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Rhabdomyosarcoma | 03/16 | | | |
NCT01836549: Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors |
|
|
| Terminated | 2 | 43 | US | imetelstat sodium, GRN163L, telomerase inhibitor GRN163L | Pediatric Brain Tumor Consortium, National Cancer Institute (NCI) | Anaplastic Astrocytoma, Anaplastic Ependymoma, Astrocytoma, Grade II, Ependymoma, Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma, Oligodendroglioma, Brainstem Tumors | 04/16 | 04/16 | | |
